BerganKDV Wealth Management’s Avanos Medical AVNS Stock Holding History

BerganKDV Wealth Management’s Portfolio AVNS Stock Details AVNS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-25	Closed	-$1K	–	933
2020 Q4	$1K	Hold	25	–	–	﹤0.01%	828
2020 Q3	$1K	Hold	25	–	–	﹤0.01%	760
2020 Q2	$1K	Hold	25	–	–	﹤0.01%	822
2020 Q1	$1K	Hold	25	–	–	﹤0.01%	786
2019 Q4	$1K	Hold	25	–	–	﹤0.01%	821
2019 Q3	$1K	Hold	25	–	–	﹤0.01%	650
2019 Q2	$1K	Hold	25	–	–	﹤0.01%	690
2019 Q1	$1K	Hold	25	–	–	﹤0.01%	680
2018 Q4	$1K	Hold	25	–	–	﹤0.01%	642
2018 Q3	$2K	Hold	25	–	–	﹤0.01%	573
2018 Q2	$1K	Buy	+25	New	+$1.32K	﹤0.01%	620

Other funds holding AVNS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

PIM

Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BerganKDV Wealth Management's AVNS Position: Q1 2021 in Review

BerganKDV Wealth Management sold out of Avanos Medical (AVNS) in Q1 2021, closing a stake of 25 shares — an estimated $1K sold.

BerganKDV Wealth Management first reported a position in AVNS in Q2 2018 and held it in 11 quarters. The position peaked at $2K in Q3 2018. 291 funds tracked by Wall St. Rank hold AVNS as of Q1 2021.

BerganKDV Wealth Management reported no remaining Avanos Medical position as of Q1 2021 after selling out during the quarter.
BerganKDV Wealth Management sold 25 Avanos Medical shares in Q1 2021, an estimated $1K.
BerganKDV Wealth Management first reported a position in Avanos Medical in Q2 2018 and held it in 11 quarters.
BerganKDV Wealth Management's Avanos Medical position peaked at $2K in Q3 2018.
291 funds tracked by Wall St. Rank held Avanos Medical as of Q1 2021.

Based on BerganKDV Wealth Management's 13F filing for Q1 2021, filed 11 May 2021.